NBC’s “The Voice” kicked off its battle round with a pairing choice that coach Adam Levine finds “impossible.” In a clip of Monday’s episode shared exclusively with TheWrap, Team ...

Dr Ruchi Gupta attended the AAAAI/WAO conference in San Diego, where she explored key updates in anaphylaxis, angioedema, and chronic spontaneous urticaria (CSU). A major highlight was the ...

Credit: Marina Demeshko/Shutterstock. The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals’ neffy 1mg (epinephrine nasal spray) for treating type one allergic reactions including ...

The FDA gave the go-ahead to a 1-mg formulation of ARS Pharmaceuticals’ epinephrine nasal spray neffy, allowing its use to treat type I allergic reactions, including anaphylaxis, in small children.

As of March 5, 2025, epinephrine nasal spray (neffy; ARS Pharmaceuticals) 1 mg is FDA approved to treat type I allergic reactions, including anaphylaxis, in children aged 4 years and older who weigh ...

A groundbreaking consensus report on anaphylaxis—the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like—has been released by the Global ...